Abstract
Four patients in whom the plasma CEA reflected the clinical course of intracranial disease are presented. We conclude that a search to explain an elevated CEA should include the central nervous system. In addition, in selected patients with brain metastases the plasma CEA is a helpful indicator of tumor control and of its response to radiation and chemotherapy.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Tormey DC, Davis TE, Waalkes TP: Tumor markers. In: Carter SK, Glatstein E, Livingston RB (eds) Principles of Cancer Treatment. McGraw-Hill Inc. 1982, pp 170–177
Lokich JJ, Zamcheck N, Lowenstein M: Sequential carcinoembryonic antigen levels in the therapy of metastatic breast cancer. Annals Internal Med 89:902–906, 1978
Wasserstrom WR, Schwartz MK, Fleisher M, Posner JB: Cerebrospinal fluid biochemical markers in central nervous system tumors: A review. Annals of Clinical and Laboratory Science. Vol. 11, No. 3, 239–251, 1981
Falkson HC, Vander Watt JJ, Portugal MA, Schoeman HS, Falkson G: Role of plasma carcinoembryonic antigen in evaluating patients with breast cancer treated with adjuvant chemotherapy. Cancer Treat Rep 63(8):1303–1309,1979
Falkson HC, Van der Watt JJ, Portugal MA, Pitout MJ, Falkson G: Carcinoembryonic antigen in patients with breast cancer. Cancer 42:1308–1313,1978
Loprinzi CL, Tormey DC, Rasmussen P, Falkson G, Davis TE, Falkson HC, Chang AYC: Prospective evaluation of carcinoembryonic antigen levels and alternating chemotherapeutic regimens in metastatic breast cancer. J Clin Oncol 4:45–56,1986
Mughal AW, Hortobagyi GN, Fritsche HA, Buzdar AU, Yap HY, Blumenschein GR: Serial plasma carcinoembryonic antigen measurements during treatment of metastatic breast cancer. JAMA 249(14):1881–1886, 1983
Haagensen DE, Barry WF, McCook TA, Giannola J, Ammirata S, Wells SA: The value of serial plasma levels of carcinoembryonic antigen and gross cyst disease fluid protein in patients with breast carcinoma and osseous metastases. Annals of Surgery 191(5):599–603,1980
Klee GG, Tallman RD, Goellner JR, Yanagihara T: Elevation of carcinoembryonic antigen in cerebrospinal fluid among patients with meningeal carcinomatosis. Proc Mayo Clinic 61(1):9–13,1986
Snitzer LS, McKinney EC, Tejada F, Sigel MM, Rosomoff HL, Zubrod CG: Cerebral metastases and carcinoembryonic antigen in CSF. N Engl J Med 293(21), 1975
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Eden, E.A., Muggia, J.M., Hiesiger, E.M. et al. Plasma carcinoembryonic antigen as an indicator of cerebral metastases. J Neuro-Oncol 8, 281–287 (1990). https://doi.org/10.1007/BF00177362
Issue Date:
DOI: https://doi.org/10.1007/BF00177362